相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Circulating high sensitivity C reactive protein concentrations and risk of lung cancer: nested case-control study within Lung Cancer Cohort Consortium
David C. Muller et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
C-reactive protein concentration and risk of selected obesity-related cancers in the Women's Health Initiative
Theodore M. Brasky et al.
CANCER CAUSES & CONTROL (2018)
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
Paul M. Ridker et al.
LANCET (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Cardio-oncology Related to Heart Failure: Common Risk Factors Between Cancer and Cardiovascular Disease
Anne Blaes et al.
HEART FAILURE CLINICS (2017)
Chronic inflammation and risk of colorectal and other obesity-related cancers: The health, aging and body composition study
Monika Izano et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
From C-Reactive Protein to Interleukin-6 to Interleukin-1 Moving Upstream To Identify Novel Targets for Atheroprotection
Paul M. Ridker
CIRCULATION RESEARCH (2016)
Inflammatory biomarkers and risk of cancer in 84,000 individuals from the general population
Kristine H. Allin et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
A Prospective Follow-up Study of the Relationship between C-Reactive Protein and Human Cancer Risk in the Chinese Kailuan Female Cohort
Gang Wang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis
Bo Zhou et al.
CANCER CAUSES & CONTROL (2014)
Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study
Anna E. Prizment et al.
CANCER CAUSES & CONTROL (2013)
Cancer Risk in Patients with Manifest Vascular Disease: Effects of Smoking, Obesity, and Metabolic Syndrome
Rob C. M. van Kruijsdijk et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
C-Reactive Protein and the Risk of Cancer: A Mendelian Randomization Study
Kristine H. Allin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis
Katriina Heikkilae et al.
CANCER CAUSES & CONTROL (2009)
Tracking of High-Sensitivity C-Reactive Protein after an Initially Elevated Concentration: The JUPITER Study
Robert J. Glynn et al.
CLINICAL CHEMISTRY (2009)
Baseline C-Reactive Protein Is Associated With Incident Cancer and Survival in Patients With Cancer
Kristine H. Allin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
C-reactive protein levels, variation in the c-reactive protein gene, and cancer risk: The Rotterdam Study
Claire Siemes et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
SM Grundy et al.
CIRCULATION (2005)
Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort
D Il'yasova et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease
GK Hansson
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Markers of inflammation and cardiovascular disease application to clinical and public health practice - A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association
TA Pearson et al.
CIRCULATION (2003)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
分享论文
